Didier Scherrer
Hoofd Techniek/Wetenschap/O&O bij ABIVAX
Vermogen: 564 574 $ op 30-04-2024
Actieve functies van Didier Scherrer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ABIVAX | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Didier Scherrer
Eerdere bekende functies van Didier Scherrer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
LFB Biotechnologies SASU
 LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Hoofd Techniek/Wetenschap/O&O | 01-06-2008 | 01-09-2009 |
AstraZeneca SAS
 AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Corporate Officer/Principal | 01-10-2005 | 01-06-2008 |
Entelos, Inc.
 Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Hoofd Techniek/Wetenschap/O&O | 01-09-2000 | 01-09-2005 |
Splicos SAS
 Splicos SAS Miscellaneous Commercial ServicesCommercial Services Splicos SAS provides therapeutic research and development services. The firm specializes in generating therapeutic leads and drug candidates for cancer, HIV, and genetic diseases. It offers technologies in the fields of alternative splicing and metastatic migration. The company was founded in 2008 and is headquartered in Montpellier, France. | Algemeen Directeur | 01-09-2009 | - |
Opleiding van Didier Scherrer
| Harvard Medical School | Doctorate Degree |
| Stanford University School of Medicine | Doctorate Degree |
| Louis Pasteur University | Doctorate Degree |
Statistieken
Internationaal
| Frankrijk | 6 |
| Verenigde Staten | 4 |
Operationeel
| Doctorate Degree | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABIVAX | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Splicos SAS
Splicos SAS Miscellaneous Commercial ServicesCommercial Services Splicos SAS provides therapeutic research and development services. The firm specializes in generating therapeutic leads and drug candidates for cancer, HIV, and genetic diseases. It offers technologies in the fields of alternative splicing and metastatic migration. The company was founded in 2008 and is headquartered in Montpellier, France. | Commercial Services |
Entelos, Inc.
Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Technology Services |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
- Beurs
- Insiders
- Didier Scherrer
- Ervaring
